Mizoribine Impurity 1 | CAS 110770-95-1 - Request Quote
Mizoribine Impurity 1
| SZ CAT No: | SZ-M183002 |
| CAS No | 110770-95-1 |
| Mol.F. | C8H15N3O6 |
| Mol.Wt. | 249.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Mizoribine Impurity 1 is chemically 2-Amino-N1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)malonamide. Mizoribine Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Mizoribine Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mizoribine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 110770-95-1
Purchase 110770-95-1
Order 110770-95-1
Enquire 110770-95-1
price of 110770-95-1
110770-95-1 Supplier
110770-95-1 Manufacturer
110770-95-1 Exporter
buy high quality Mizoribine Impurity 1
Purchase Mizoribine Impurity 1
Mizoribine Impurity 1 suppliers
Mizoribine Impurity 1 manufacturers
Mizoribine Impurity 1 price
Order Mizoribine Impurity 1
Enquire Mizoribine Impurity 1
Mizoribine Impurity 1 cost
Mizoribine Impurity 1 Supplier
Mizoribine Impurity 1 Distributor
Mizoribine Impurity 1 for Method Validation
Mizoribine Reference Standard
Mizoribine Impurity 1 for ANDA Filing
Mizoribine Impurity 1 for Forced Degradation Studies
Mizoribine Impurity 1 Identification Standards
Mizoribine Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.